Ogawa Ryohei, Kagiya Go, Kodaki Tsutom, Fukuda Shigekazu, Yamamoto Kazutaka
Department of Radiological Sciences, Graduate School of Medicine and Pharmaceutical, University of Toyama, Toyama, Japan.
Biotechniques. 2007 May;42(5):628-33. doi: 10.2144/000112436.
Synthetic oligonucleotides containing one of four kinds of cis-acting elements, binding sites for activating protein-1 (AP-1), nuclear factor kappaB (NF-kappaB), CArG binding factor A (CBF-A), and nuclear factor Y (NF-Y), were randomly ligated to construct DNA fragments. These fragments were inserted into the SalI site of a promoter probe vector; pGL3-TATASal, which is located immediately upstream of the TATA box sequence of the human heme oxygenase 1 gene and linked to the luciferase gene to construct 11 plasmid vectors. When these vectors were introduced into PC-3 cells of human prostate cancer, 6 out of the 11 transfectants showed a significantly higher luciferase activity than pGL3-TATASal. The two strongest promoters (clone 6 and clone 11) were investigated further Clone 6 turned out to be the strongest, showing a 3.0- and 8.4-fold activity in comparison to the two frequently used promoters--the cytomegalovirus (CMV) immediate early promoter and the simian virus 40 (SV40) early promoter respectively. Clone 11 was less active than clone 6, but still showed higher activity than the two promoters. When the plasmids were introduced into nine other cell lines, their activities varied but were still comparable to the two promoters. These results indicate that the method used here is simple and efficient for constructing strong promoters that are potentially useful for vectors in either gene therapy or recombinant vaccine.
含有四种顺式作用元件之一(即激活蛋白-1(AP-1)、核因子κB(NF-κB)、CArG结合因子A(CBF-A)和核因子Y(NF-Y)的结合位点)的合成寡核苷酸被随机连接以构建DNA片段。这些片段被插入到一个启动子探针载体的SalI位点;pGL3-TATASal,其位于人血红素加氧酶1基因TATA框序列的紧邻上游,并与荧光素酶基因相连以构建11个质粒载体。当将这些载体导入人前列腺癌的PC-3细胞时,11个转染子中有6个显示出比pGL3-TATASal显著更高的荧光素酶活性。对两个最强的启动子(克隆6和克隆11)进行了进一步研究。结果表明克隆6是最强的,与两个常用启动子——巨细胞病毒(CMV)立即早期启动子和猿猴病毒40(SV40)早期启动子相比,分别显示出3.0倍和8.4倍的活性。克隆11的活性低于克隆6,但仍比这两个启动子的活性高。当将这些质粒导入其他九种细胞系时,它们的活性有所不同,但仍与这两个启动子相当。这些结果表明,此处使用的方法对于构建在基因治疗或重组疫苗载体中可能有用的强启动子而言简单且高效。